The Impact of Statin Therapy on Postoperative Short- and Long-term Mortality and Morbidity After Non-Cardiac Surgery.

Clicks: 16
ID: 332168
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #223 of 286 articles by views in european journal of preventive cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 286 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
AIMS: Statins' anti-inflammatory and endothelial-stabilising effects suggest perioperative value, but trials of de novo initiation were discredited following research misconduct. Whether established preoperative statin therapy lowers postoperative mortality dose-dependently remains unclear. METHODS: We studied 56,362 patients aged ≥45 years undergoing non-cardiac surgery at two university hospitals (2016-2023). Preoperative statin exposure was assessed as status (any vs none), intensity (high vs low/intermediate), and regimen (high vs low/intermediate vs none). Primary outcomes were 30- and 365-day mortality. Inverse probability of treatment weighting, using random forest-estimated propensity scores targeting the average treatment effect in the treated, was applied to balance measured confounders. Associations were estimated with weighted Cox regression. RESULTS: Overall, 372 patients (0.6%) died within 30 days and 3,735 (6.6%) within 365 days. After weighting, all covariates were balanced. Statin therapy showed a directionally consistent but non-significant association with lower 30-day mortality (HR 0.78; 95% CI 0.57-1.07), and was associated with lower 365-day mortality (HR 0.81; 95% CI 0.73-0.90; ARD -1.2 percentage points; number needed to treat 83). A dose-response relationship was evident: versus no statin, high-intensity therapy showed a 29% lower hazard (HR 0.71; 95% CI 0.60-0.83; ARD -2.3 points) and low/intermediate-intensity a 16% lower hazard (HR 0.84; 95% CI 0.74-0.96). Findings were consistent across sensitivity analyses. CONCLUSIONS: Among adults undergoing non-cardiac surgery, established preoperative statin therapy was associated with dose-dependent lower 365-day mortality. These findings suggest perioperative statin continuation as a preventive strategy and warrant confirmation in a randomised trial.
Reference Key
openalex_W7221559208 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Max Bell, Albert Bremberg, Linda Mellbin, Arman Valadkhani
Are you one of these authors? Claim your profile
Journal european journal of preventive cardiology
Year 2026
DOI
10.1093/eurjpc/zwag532
URL
https://doi.org/10.1093/eurjpc/zwag532
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.